"The future looks bright as far as a cure," one top HIV cure researcher told LGBTQ Nation.

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, VH184 and VH499.

A new single-pill treatment for HIV has shown promising results. This is particularly useful for people who have had HIV for decades.

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could ...

As GSK’s HIV unit ViiV Healthcare grapples with a new rival in the injectable HIV prevention and treatment field, the company is reinforcing the staying power of its long-acting treatment Cabenuva | ...

For more than 40 years, scientists have chased a virus that refuses to stand still. HIV mutates quickly, hiding in long-lived cells and forming what are known as viral reservoirs, one of the main ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

Researchers here presented what they said is the first evidence demonstrating that benefits paid through the Supplemental Nutrition Assistance Program, or SNAP, can improve a person’s adherence to HIV ...

One-third of children with HIV who received very early ART had no detectable virus in their body for at least 12 weeks after stopping treatment, according to study findings. It was another sign that ...

Steatotic liver disease is an increasingly recognised comorbidity linked to HIV treatment.